Shionogi
Daniel Bou Absi has a diverse work experience, primarily in regulatory affairs. Daniel is currently the Director of Regulatory Affairs at Shionogi Inc., starting in April 2022. Prior to this role, they held various positions at Shionogi Inc., including Regulatory Affairs Associate Director, Regulatory Affairs Senior Manager, and Regulatory Affairs Manager, from 2011 to 2022. Before joining Shionogi Inc., they worked as a Content Manager at Boehringer Ingelheim Pharmaceuticals in 2011, and as a Content Coordinator at Bristol-Myers Squibb in Princeton, New Jersey from 2009 to 2011.
Daniel Bou Absi attended Rutgers University from 2006 to 2008, where they pursued a Bachelor of Applied Science (B.A.Sc.) degree in Graphic Design.
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.